this paper presents a review of the literature on the therapeutic action and the side effects of the two main dopaminergic agents : l-dopa/decarboxylase inhibitor ( l-dopa/di ) and bromocriptine ( parlodel used either as monotherapy or in combination in patients with parkinson 's disease .
C0006230
bromocriptine
C0030567
parkinson 's disease